Literature DB >> 32161204

The association of the visceral adiposity index with insulin resistance and beta-cell function in Korean adults with and without type 2 diabetes mellitus.

Hyun Ho Sung1, Chang Eun Park2, Mi Young Gi3, Ju Ae Cha4, Ae Eun Moon5, Jae Kook Kang5, Jeong Min Seong6, Jun Ho Lee7, Hyun Yoon7.   

Abstract

This study was conducted to assess the association of the visceral adiposity index (VAI) with insulin resistance and beta cell function in Korean adults with and without type 2 diabetes mellitus. The study was carried out using data from the 2015 Korean National Health and Nutrition Examination Survey (KNHANES VI-3) and included 4,922 adults, aged 20 or older. There were several key findings in the present study. First, in subjects without type 2 diabetes mellitus, homeostasis model assessment of insulin resistance (HOMA-IR) (p < 0.001) and beta cell function (HOMA-B) (p < 0.001), insulin (p < 0.001), fasting blood glucose (FBG) (p < 0.001), and metabolic syndrome (MetS) score (p < 0.001) were positively associated with quartiles of VAI. Second, in subjects with type 2 diabetes mellitus, HOMA-IR (p = 0.038), FBG (p = 0.007), and MetS score (p < 0.001) were positively associated with quartiles of VAI, but associations with HOMA-B (p = 0.879) and insulin (p = 0.104) were not significant. In conclusions, the visceral adiposity index is positively associated with insulin resistance and beta cell function in Korean adults without type 2 diabetes mellitus. The visceral adiposity index is positively associated with insulin resistance but not beta cell function in Korean adults with type 2 diabetes mellitus.

Entities:  

Keywords:  Beta-cell function; Insulin resistance; Visceral adiposity index

Mesh:

Year:  2020        PMID: 32161204     DOI: 10.1507/endocrj.EJ19-0517

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


  4 in total

1.  Usefulness of four surrogate indexes of insulin resistance in middle-aged population in Hefei, China.

Authors:  Rui Huang; Zi Cheng; Xingyi Jin; Xuemin Yu; Jinhui Yu; Yunpeng Guo; Li Zong; Jie Sheng; Xing Liu; Sufang Wang
Journal:  Ann Med       Date:  2022-12       Impact factor: 4.709

Review 2.  The Accuracy of Visceral Adiposity Index for the Screening of Metabolic Syndrome: A Systematic Review and Meta-Analysis.

Authors:  Moniba Bijari; Sara Jangjoo; Nima Emami; Sara Raji; Mahdi Mottaghi; Roya Moallem; Ali Jangjoo; Amin Saberi
Journal:  Int J Endocrinol       Date:  2021-07-26       Impact factor: 3.257

3.  Biomarker-based visceral adiposity score and incident type 2 diabetes in the multiethnic cohort.

Authors:  Gertraud Maskarinec; Phyllis Ash Raquinio; Veronica W Setiawan; Thomas Ernst; Adrian A Franke; Steven D Buchthal; John A Shepherd; Lynne R Wilkens; Unhee Lim; Loïc Le Marchand
Journal:  Ann Epidemiol       Date:  2021-07-21       Impact factor: 6.996

Review 4.  The Visceral Adiposity Index in Non-Alcoholic Fatty Liver Disease and Liver Fibrosis-Systematic Review and Meta-Analysis.

Authors:  Abdulrahman Ismaiel; Ayman Jaaouani; Daniel-Corneliu Leucuta; Stefan-Lucian Popa; Dan L Dumitrascu
Journal:  Biomedicines       Date:  2021-12-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.